newsfilter
← Latest News
GlobeNewswire·

OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review

BETHLEHEM, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) ("OraSure" and "OTI"), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced